Expression of receptor activator of NF-kB ligand (RANKL) on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

被引:0
|
作者
Heider, U
Jakob, C
Zavrski, I
Langelotz, C
Fleissner, C
Schulz, CO
Eucker, J
Possinger, K
Hofbauer, LC
Sezer, O
机构
[1] Universitatsklinikum Charite, Dept Hematol & Oncol, Berlin, Germany
[2] Univ Marburg, Dept Gastroenterol Endocrinol & Metab, D-35032 Marburg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3190
引用
收藏
页码:808A / 808A
页数:1
相关论文
共 50 条
  • [31] Soy protein and n-3 fatty acids prevent receptor activator of NF-kB ligand (RANKL) expression and osteoporosis in ovariectomized mice
    Fernandes, G
    Sun, DX
    Krishnan, A
    Zaman, K
    Lawrence, R
    FASEB JOURNAL, 2002, 16 (04): : A625 - A625
  • [32] THE ROLE OF EXPRESSION CD56 ON BONE MARROW PLASMA CELLS AND EXTRAMEDULLARY PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA
    Firsova, M.
    Mendeleeva, L.
    Kovrigina, A.
    Soloviev, M.
    Pokrovskaya, O.
    Nareyko, M.
    Kuzmina, L.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 795 - 796
  • [33] Relationship between Bone Marrow PD-1 and PD-L1 Expression and the Presence of Osteolytic Bone Disease in Multiple Myeloma Patients
    Costa, Federica
    Bolzoni, Marina
    Vescovini, Rosanna
    Accardi, Fabrizio
    Dalla Palma, Anna Benedetta
    De Luca, Federica
    Marchica, Valentina
    Toscani, Denise
    Vicario, Emanuela
    Storti, Paola
    Aversa, Franco
    Giuliani, Nicola
    BLOOD, 2018, 132
  • [34] DNA methylation in peripheral blood and bone marrow mononuclear cells from patients with multiple myeloma.
    Borzecki, A
    Rolinski, J
    Borzecka, H
    Keith, G
    Sieklucka-Dziuba, M
    Kaluzny, Z
    Dmoszynska, A
    BLOOD, 2000, 96 (11) : 221B - 221B
  • [35] EXPRESSION OF THE BONE REMODELLING PROTEINS OSTEOPROTEGERIN (OPG) AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR kB LIGAND (RANKL) IN HUMAN AND BOVINE MILK
    Kanczler, J.
    Owens, S.
    Willmott, C.
    Bodamyali, T.
    Millar, T.
    Blake, D.
    Stevens, C.
    RHEUMATOLOGY, 2002, 41 : 35 - 35
  • [36] Quantification of plasma cells using digital pathology software in bone marrow trephine biopsies of multiple myeloma.
    Nandi, N. P. K.
    JOURNAL OF PATHOLOGY, 2023, 261 : S32 - S32
  • [37] miRNA in Serum and Bone Marrow Plasma Cells From Multiple Myeloma Patients
    Stiff, Andrew
    Rocci, Alberto
    Hofmeister, Craig C.
    Omede, Paola
    Geyer, Susan
    Bringhen, Sara
    Cascione, Luciano
    Bingman, Anissa
    Gambella, Manuela
    Cavallo, Federica
    De Luca, Luciana
    Guan, Jingwen
    Larocca, Alessandra
    Corry, Jacqueline
    Gay, Francesca
    Efebera, Yvonne A.
    Uccello, G.
    Benson, Don M., Jr.
    Talabere, Tiffany
    Murnan, Kevin
    Valeria, Magarotto
    Boccadoro, Mario
    Croce, Carlo M.
    Palumbo, Antonio
    Pichiorri, Flavia
    BLOOD, 2012, 120 (21)
  • [38] Receptor activator of nuclear factor-kB ligand (RANKL) and bone mineral density in Tunisian patients with chronic obstructive pulmonary disease (COPD)
    Mjid, Meriem
    Laadhar, Lilia
    Taboubi, Amir
    Ayadi, Imene
    Hedhli, Abir
    Ouahchi, Yacine
    Aoudani, H.
    Rouhou, Sana Cheik
    Merai, Samira
    Sellami, Maryam
    Toujani, Sonia
    Dhahri, Besma
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [39] Expression of Wnt-Inhibitors and SDF-1 in Whole Bone Marrow Biopsies in Association to the Osteolytic Bone Disease of Multiple Myeloma
    Kristensen, Ida Bruun
    Haaber, Jacob
    Lyng, Maria B.
    Pedersen, Lise
    Rasmussen, Lars Melholt
    Ditzel, Henrik J.
    Abildgaard, Niels
    BLOOD, 2012, 120 (21)
  • [40] The system of osteoprotegrin (OPG)/ligand of NF-kB receptor activator (RANKL) in patients with diabetes mellitus, mediacalcinosis and obliterating atherosclerosis of lower leg arteries
    Yaroslavtseva, M. V.
    Ul'yanova, I. N.
    Galstyan, G. R.
    Ilin, A. V.
    Nikankina, L. V.
    Remizov, O. V.
    Dedov, I. I.
    DIABETES MELLITUS, 2009, 12 (01): : 25 - 28